Cryoprecipitated Antihemophilic Factor from Japan
Cryoprecipitate from fresh frozen plasma containing Factor VIII, fibrinogen, and von Willebrand factor for therapeutic clotting support. Under HTS 3002.90.52 as other animal/human blood products prepared for therapeutic uses. Commonly used in surgical bleeding management.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Ensure donor screening records accompany shipment to verify safety from blood-borne pathogens
• Classify based on primary therapeutic fraction; avoid bulk plasma categorization
• Coordinate with CBP for prior notice under Bioterrorism Act for human blood products